when did retatrutide come out Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Retatrutide FDA Approval Status 2026:
Description
Gastric bypass patients asking about GLP-1 therapy need specialized guidance

Glucagon-like peptide-1 (GLP-1) receptor agonists, originally developed for type 2 diabetes, have emerged as promising candidates due to effects on intake regulation and reward processing

France renews Early Access to Novos Wegovy for Obesity

But when used without guidance, the risks grow quickly: malnutrition from rapid weight loss, dehydration, muscle atrophy, gallbladder issues, and gastrointestinal complications

Learn about new safety warnings for GLP-1 drugs like Mounjaro, Trulicity, Saxenda, Byetta, Victoza, and more
